Prestige floats $100 mil. note for Blacksmith buy
This article was originally published in The Tan Sheet
Executive Summary
Prestige Brands sells $100 million worth of debt to help finance its acquisition of Blacksmith Brands. The senior notes the firm announced Oct. 22 will have the same terms as the 8.25 percent notes the company issued in March and are due in 2018. Prestige Sept. 20 announced its $190 million acquisition of year-old Blacksmith, which markets brands including denture products Efferdent and Effergrip, cough and cold products PediaCare and Luden's and allergy drug NasalCrom (1"The Tan Sheet" Sept. 27, 2010)
You may also be interested in...
Prestige Brands Makes "Seismic Shift" To OTC With Blacksmith Acquisition
On the eve of Blacksmith Brands' one-year anniversary, co-founder and CEO Peter Mann fulfills his promise to cash in on the startup in a $190 million sale to Prestige Brands Holdings, which Mann also helped launch
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.